Market Value680,804,000
Total Holdings58
File Date2021-05-18
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ADMS / Adamas Pharmaceuticals Inc
KALV / KalVista Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
MCRB / Seres Therapeutics, Inc.
FGEN / FibroGen, Inc.
CKPT / Checkpoint Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
LPTX / Leap Therapeutics, Inc.
SIOX / Sio Gene Therapies Inc.
AYLA / Ayala Pharmaceuticals Inc
IMVT / Immunovant, Inc.
GBPT / Globe Photos Inc
ALPN / Alpine Immune Sciences, Inc.
CMRX / Chimerix, Inc.
VIRX / Viracta Therapeutics, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
CCXI / ChemoCentryx Inc
PRAX / Praxis Precision Medicines, Inc.
AKUS / Akouos Inc
CFRX / ContraFect Corp
MGTA / Magenta Therapeutics Inc
TCDA / Tricida Inc
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TARA / Protara Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CNCE / Concert Pharmaceuticals Inc
MYOV / Myovant Sciences Ltd
CBIO / Crescent Biopharma, Inc.
AFIB / Acutus Medical, Inc.
AVEO / AVEO Pharmaceuticals Inc
APTO / Aptose Biosciences Inc.
PCVX / Vaxcyte, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
MEIP / MEI Pharma, Inc.
BHVN / Biohaven Ltd.
SMTI / Sanara MedTech Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
AVTX / Avalo Therapeutics, Inc.
GMTX / Gemini Therapeutics Inc
OPTN / OptiNose, Inc.
MRUS / Merus N.V.
CLDX / Celldex Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
STXS / Stereotaxis, Inc.
PRQR / ProQR Therapeutics N.V.
CRDF / Cardiff Oncology, Inc.
INFI / Infinity Pharmaceuticals Inc.
SRRA / Sierra Oncology Inc
STRO / Sutro Biopharma, Inc.
LUMO / Lumos Pharma, Inc.
TCON / TRACON Pharmaceuticals, Inc.
KZR / Kezar Life Sciences, Inc.
NLTX / Neoleukin Therapeutics, Inc.
FBIO / Fortress Biotech, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
VSTM / Verastem, Inc.
CYTK / Cytokinetics, Incorporated
MGNX / MacroGenics, Inc.
AADI / Aadi Bioscience, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
TGTX / TG Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
XOMA / XOMA Royalty Corporation
CRNX / Crinetics Pharmaceuticals, Inc.
TELA / TELA Bio, Inc.
ETON / Eton Pharmaceuticals, Inc.
EPIX / ESSA Pharma Inc.
HROW / Harrow, Inc.
CDXS / Codexis, Inc.
PTGX / Protagonist Therapeutics, Inc.
US33830X1046 / Five Prime Therapeutics Inc